SUMMARY The levels of plasma carcinoembryonic antigen (CEA) were estimated in 59 control subjects attending St Mark's Hospital and in 139 patients with uncomplicated ulcerative colitis. There was little difference in the CEA levels in the two groups. In the colitic patients, the actual CEA values could not be correlated with the age of the patient, the activity of the disease, the extent of bowel involvement, or the length of history.
correlate the findings with various clinical aspects of the disease. In particular, we wished to see whether or not CEA levels could be correlated with the presence of carcinoma or of dysplastic epithelial changes without carcinoma (Morson and Pang, 1967) .
Technical Details
Ten ml of blood obtained by venepuncture was collected into bottles containing edetic acid. After centrifuging, the plasma was stored at -20°C within three hours of collection until transferred to the Chester Beatty Institute for storage at -70°C.
Carcinoembryonic antigen was estimated at this Institute by a modification of the double-antibody technique described by Egan, Lautenschleger, Coligan, and Todd (1972) . Clinical details were not available to the technicians performing the CEA estimations and the results were not correlated with the clinical state of the patients until the end of the study. There were seven patients in this group in whom the dysplastic changes found in the rectal mucosal biopsy were severe enough to fulfil the criteria described by Morson and Pang (1967) 
Groups of Patients

Results
The overall results are shown in figure 1. All the 70 healthy control subjects from the Chester Beatty Institute had CEA levels of less than 17-5 ng/ml. group.bmj.com on October 13, 2017 -Published by http://gut.bmj.com/ Downloaded from difference in the values between the two control groups might be explained by the suggestion that CEA levels may be raised in other conditions so far uninvestigated. This study emphasizes the importance of using, as controls, subjects from a population similar to that under investigation.
Previous work in patients with ulcerative colitis has suggested that CEA levels may be related to the age of the patient (Rule, Goleski-Reilly, Sachar, Vandevoorde, and Janowitz, 1973) , the length of history and the extent of the disease (Rule et al, 1972) , and to the activity of the disease (Rule et al, 1972; Moore, Kantrowitz, and Zamcheck, 1972; Khoo, Hunt, and Mackay, 1973) . In contradistinction to these authors, the present study of a considerably larger series of patients showed no relationship to any of these features. This corroborates the findings in two other British series. Wight and Gazet (1972) , and Booth, King, Leonard, and Dykes (1973) investigated 30 and 61 colitic patients respectively and were unable to demonstrate any correlation between CEA levels and the clinical features already mentioned. The actual CEA levels have not been given in table III because the methods of assay have varied. Four out of the five patients with dysplasia previously reported showed CEA levels within the normal range for the method used. Our experience is similar in that only one of our seven patients with this change had a level greater than that shown by the St Mark's Hospital control population.
Among the four patients with carcinoma in colitis already reported, a normal CEA value was found in the patient described by Booth et al (1973) , using a technique similar to that of the present study . Moore et al (1972) , using a less sensitive technique, found a persistently positive serum assay in their only patient with coexistent carcinoma. found that CEA was not detectable in serum from colitic patients after extraction with perchloric acid unless the patient had a coexistent carcinoma. This occurred in their two patients with carcinoma and, as a result, they stated that CEA assay was a useful means of detecting carcinomatous change in ulcerative colitis. Owing to technical differences in the method of assay, it has not proved possible to substantiate or refute the findings of for the seven patients with carcinoma and colitis in this series.
In the present study, only one of the seven patients with established carcinoma in ulcerative colitis had a CEA level (105 ng/ml) outside the control range (table II case 2). It is interesting that the CEA level in this patient fell to 52 5 ng/ml one week after total proctocolectomy, to 30-8 ng/ml two weeks postoperatively, and to 18-0 ng/ml three months later.
These disappointing findings of a raised CEA level in only one patient in each group of those with dysplasia or carcinoma show that little help is to be expected in the early detection of malignant change in patients especially at risk, and that with established carcinoma this test is no more helpful than conventional investigations. However, it may be worthwhile to perform serial CEA estimations in any patient where the preoperative level is raised in the presence of carcinoma in colitis to act as a monitor of the completeness of excision.
In this study CEA values in ulcerative colitis have shown no correlation with the length of history, the extent of the disease, or the degree of activity. It seems unlikely that malignant change would be detected by this test earlier than by other methods of investigation and we see no value in routine CEA estimations in patients with ulcerative colitis. 
